---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039745"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T17:49:55.965697+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals (MGRX) gets Nasdaq notice for equity of $1.35M vs $2.5M minimum

## Summary
- Stockholders' equity of $1,354,821 as of Sep 30, 2023, below Nasdaq's $2.5M continued listing requirement.
- Must submit a compliance plan by Dec 18, 2023; Nasdaq may grant up to 180-day extension if plan accepted.
- Company also not in compliance with minimum bid price of $1.00 per share, previously reported.
- Failure to regain compliance could result in delisting; management is evaluating options to address the deficiency.

## SEC filing metadata
- accession: 0001493152-23-039745
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315223039745/0001493152-23-039745-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315223039745/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039745
- JSON: https://secwatch.observer/filing/0001493152-23-039745.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039745.txt

## Key facts
- Listing & Compliance Notices
  MANGOCEUTICALS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: companies listed on the Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000. In the Company’s Form 10-Q, the Company reported stockholders’ equity of $1,354,821, which is below the minimum stockholders’ equity required for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1). Additionally, as of the date of this Report, the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1938046/000149315223039745/0001493152-23-039745-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.